Kristen Kluska

Tazeen Ahmad

Yaron Werber

Yigal Nochomovitz

Anupam Rama

Gena Wang

Jack Allen

Joseph Schwartz

Joon Lee

Liisa Bayko

Luca Issi

Maury Raycroft

Mehdi Goudarzi

Salveen Richter

Christopher Raymond

Dae Gon Ha

Daniel Smith

Ed Arce

Farzin Haque

Hannah Wei

Huidong Wang

Jeff Hung

Laura Chico

Malcolm Kuno

Maurice Raycroft

Maxwell Skor

Michael Riad

Sami Corwin

Shelby Hill

Tommie Reerink

Will Soghikian

Wing Yip

- Ultragenyx Pharmaceutical announced on **October 8, 2025**, that the Italian Medicines Agency (AIFA) has **extended reimbursement for Evkeeza (evinacumab)** for the treatment of Homozygous Familial Hypercholesterolemia (HoFH) in Italy.  **[1515673_dbdf121f56274a2c93034222626d0efb_0]** 
- The extended reimbursement now includes **pediatric patients aged 6 months and older**, expanding from the previous coverage for patients aged 12 years and older, which began in **October 2023**.  **[1515673_dbdf121f56274a2c93034222626d0efb_0]** 
- Evkeeza is a therapy for HoFH, a rare inherited disease causing dangerously high LDL-C, and is administered via **monthly infusion**.  **[1515673_dbdf121f56274a2c93034222626d0efb_0]** **[1515673_dbdf121f56274a2c93034222626d0efb_1]**

Ultragenyx Announces Extended Reimbursement for Evkeeza in Italy

Ultragenyx Pharmaceutical (RARE)